SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-176816
Filing Date
2018-05-29
Accepted
2018-05-29 16:21:33
Documents
3
Period of Report
2018-05-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d595409d8k.htm 8-K 23940
2 EX-99.1 d595409dex991.htm EX-99.1 9677
3 GRAPHIC g5954091rgnx-ex99.gif GRAPHIC 7451
  Complete submission text file 0001193125-18-176816.txt   45511
Mailing Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850
Business Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37553 | Film No.: 18864735
SIC: 2836 Biological Products, (No Diagnostic Substances)